Pediatric Crohn disease activity index: Responsive to short-term change

Journal of Pediatric Gastroenterology and Nutrition

Volumn 36, Issue 1, 2003, Pages 83-89

  Kundhal, P S ^a   Critch, J N ^a,c   Zachos, M ^a   Otley, A R ^b   Stephens, D ^a   Griffiths, A M ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL PRACTICE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE EXACERBATION; HUMAN; MEDICAL ASSESSMENT; PRIORITY JOURNAL; TREATMENT OUTCOME; ADOLESCENT; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ENTERIC FEEDING; FEMALE; HOSPITALIZATION; MALE; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ROC CURVE; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; CROHN DISEASE; ENTERAL NUTRITION; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 1842844069     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200301000-00016     Document Type: Article

References (28)

1. Best WR, Becktel JM, Singleton JW et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70:439-14.
2. Hyams JS, Ferry GD, Mandel FS et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991; 12:439-47.
3. Sandborn WJ, Feagan BG, Hanauer SB et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002; 122:512-30.
4. Hyams JS, Mandel F, Ferry GD et al. Relationship of common laboratory parameters to the activity of Crohn's disease in children. J Pediatr Gastroenterol Nutr 1992; 14:216-22.
5. Otley A, Loonen H, Parekh N et al. Assessing activity of pediatric Crohn's disease: which index to use? Gastroenterology 1999; 116:527-31.
6. Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 1987; 40:171-78.
7. Kirshner B, Guyatt G. A methodological framework for assessing health indices. J Chronic Dis 1985; 38:27-36.
8. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials 1991; 12(4 Suppl):142S-158S.
9. Hyams JS, Davis P, Grancher K et al. Clinical outcome of ulcerative colitis in children. J Pediatr 1996; 129:81-8.
10. Guyatt GH, Deyo RA, Charlson M et al. Responsiveness and validity in health status measurement: a clarification. J Clin Epidemiol 1989; 42:403-08.
11. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989; 170:2-6.
12. Griffiths AM, Pendley FC, Issenman RM et al. Elemental versus polymeric enteral nutrition as primary therapy for active Crohn's disease: a multi-centre pediatric randomized controlled trial. J Pediatr Gastroenterol Nutr 2000; 31:S75-S76.
13. Kazis LE, Larson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989;(27):S178.
14. Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopedic evaluation. Med Care 1990; 28:632-42.
15. Cohen J. Statistical Power Analysis for the Behavioural Sciences. New York: Academy Press, 1977.
16. Beaton DE, Hogg-Johnson S, Bombardier C. Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders. J Clin Epidemiol 1997; 50:79-93.
17. Sandborn WJ, Feagan BG, Hanauer SB et al. An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial. Gastroenterology 2001; 120:1330-38.
18. Targan SR, Hanauer SB, van Deventer SJ et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Eng J Med 1997; 337(15):1029-35.
19. Liang MH. Evaluating measurement responsiveness. J Rheumatol 1995; 22:1191-92.
20. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2 ed. New Jersey: Lawrence Erlbaum Associates, 1988.
21. Fransen J, Hauselmann H, Michel BA et al. Responsiveness of the self-assessed rheumatoid arthritis disease activity index to a flare of disease activity. Arthritis Rheum 2001; 44:53-60.
22. Silverstein B, Kilgore KM, Fisher WP et al. Applying psychometric criteria to functional assessment in medical rehabilitation: I. Exploring unidimensionality. Arch Phys Med Rehabil 1991; 72:631-37.
23. Silverstein B, Fisher WP, Kilgore KM et al. Applying psychometric criteria to functional assessment in medical rehabilitation: II. Defining interval measures. Arch Phys Med Rehabil 1992; 73:507-18.
24. Nunnally JC, Bernstein IH. Psychometric Theory. 3 ed. New York: McGraw-Hill, 1994.
25. Markowitz J, Grancher K, Kohn N et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000; 119:895-902.
26. Norman GR. Issues in the use of change scores in randomized trials. J Clin Epidemiol 1989; 42:1097-1105.
27. Beaton DE, Bombardier C, Katz JN et al. A taxonomy for responsiveness. J Clin Epidemiol 2001; 54:1204-17.
28. Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002; 122: 512-30.